Related Experiment Video

Updated: Jun 17, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

CXCL8 and its cognate receptors in melanoma progression and metastasis

Seema Singh1, Ajay P Singh, Bhawna Sharma

  • 1Department of Oncologic Sciences, Mitchell Cancer Institute, University of South Alabama, AL, USA.

Future Oncology (London, England)
|December 22, 2009
PubMed

Insights

Melanoma incidence is increasing, and effective treatments are lacking. This review explores the role of CXCL8 and its receptors in melanoma progression and metastasis, highlighting their potential as therapeutic targets.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Melanoma incidence is rising globally, with limited treatment options for metastatic disease.
  • Early-stage melanoma is curable via surgery, but advanced stages pose significant therapeutic challenges.

Purpose of the Study:

  • To review the current understanding of CXCL8 and its receptors (CXCR1 and CXCR2) in melanoma.
  • To highlight the functional implications of the CXCL8/CXCR1/CXCR2 axis in melanoma progression and metastasis.
  • To underscore the potential of targeting this pathway for novel melanoma therapies.

Main Methods:

  • Literature review of recent studies on CXCL8 and its receptors in melanoma.
  • Analysis of functional roles in melanoma pathogenesis, progression, and metastasis.
  • Synthesis of evidence supporting therapeutic targeting.

Main Results:

  • CXCL8 and its receptors CXCR1/CXCR2 are implicated in multiple facets of melanoma.
  • These molecules play significant roles in melanoma cell proliferation, survival, invasion, and angiogenesis.
  • Evidence suggests involvement in immune evasion and the formation of a pro-tumorigenic microenvironment.

Conclusions:

  • The CXCL8/CXCR1/CXCR2 pathway is a critical regulator of melanoma progression and metastasis.
  • Targeting CXCL8 or its receptors presents a promising therapeutic strategy for melanoma.
  • Further research into this axis may lead to the development of effective treatments for advanced melanoma.

More Related Videos

Experimental Metastasis Assay08:28

Experimental Metastasis Assay

Published on: August 24, 2010

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease06:25

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

Published on: March 29, 2024

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Chemotaxis and Direction of Cell Migration01:21

Chemotaxis and Direction of Cell Migration

Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon towards...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...